AdoRN Trial: Atezolizumab in combination with neoadjuvant chemotherapy and interval cytoreductive surgery for patients with newly-diagnosed advanced-stage epithelial ovarian cancer
Publication
, Conference
Gaillard, S; Duska, L; Broadwater, G; McNally, L; Lee, P; Davidson, B; Previs, R; Moss, H; Berchuck, A; Nixon, A; Yi, J; Bookman, M; Secord, AA
Published in: GYNECOLOGIC ONCOLOGY
2021
Duke Scholars
Published In
GYNECOLOGIC ONCOLOGY
EISSN
1095-6859
ISSN
0090-8258
Publication Date
2021
Volume
162
Start / End Page
S61 / S61
Related Subject Headings
- Oncology & Carcinogenesis
- 3215 Reproductive medicine
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1114 Paediatrics and Reproductive Medicine
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Gaillard, S., Duska, L., Broadwater, G., McNally, L., Lee, P., Davidson, B., … Secord, A. A. (2021). AdoRN Trial: Atezolizumab in combination with neoadjuvant chemotherapy and interval cytoreductive surgery for patients with newly-diagnosed advanced-stage epithelial ovarian cancer. In GYNECOLOGIC ONCOLOGY (Vol. 162, pp. S61–S61).
Gaillard, Stephanie, Linda Duska, Gloria Broadwater, Leah McNally, Paula Lee, Brittany Davidson, Rebecca Previs, et al. “AdoRN Trial: Atezolizumab in combination with neoadjuvant chemotherapy and interval cytoreductive surgery for patients with newly-diagnosed advanced-stage epithelial ovarian cancer.” In GYNECOLOGIC ONCOLOGY, 162:S61–S61, 2021.
Gaillard S, Duska L, Broadwater G, McNally L, Lee P, Davidson B, et al. AdoRN Trial: Atezolizumab in combination with neoadjuvant chemotherapy and interval cytoreductive surgery for patients with newly-diagnosed advanced-stage epithelial ovarian cancer. In: GYNECOLOGIC ONCOLOGY. 2021. p. S61–S61.
Gaillard, Stephanie, et al. “AdoRN Trial: Atezolizumab in combination with neoadjuvant chemotherapy and interval cytoreductive surgery for patients with newly-diagnosed advanced-stage epithelial ovarian cancer.” GYNECOLOGIC ONCOLOGY, vol. 162, 2021, pp. S61–S61.
Gaillard S, Duska L, Broadwater G, McNally L, Lee P, Davidson B, Previs R, Moss H, Berchuck A, Nixon A, Yi J, Bookman M, Secord AA. AdoRN Trial: Atezolizumab in combination with neoadjuvant chemotherapy and interval cytoreductive surgery for patients with newly-diagnosed advanced-stage epithelial ovarian cancer. GYNECOLOGIC ONCOLOGY. 2021. p. S61–S61.
Published In
GYNECOLOGIC ONCOLOGY
EISSN
1095-6859
ISSN
0090-8258
Publication Date
2021
Volume
162
Start / End Page
S61 / S61
Related Subject Headings
- Oncology & Carcinogenesis
- 3215 Reproductive medicine
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1114 Paediatrics and Reproductive Medicine
- 1112 Oncology and Carcinogenesis